A Case report of a continuous ambulatory drug delivery (CADD) pump to deliver opioid agonist treatment in an acute care setting

被引:0
|
作者
Wigg, Casey [1 ]
Nolen, Amy [2 ]
Jauhal, Lisa [3 ]
Sharma, Malika [4 ]
机构
[1] Sunnybrook Hlth Sci Ctr, 2075 Bayview Ave,Room H266, Toronto, ON M4N 3M5, Canada
[2] Sunnybrook Hlth Sci Ctr, 2075 Bayview Ave,Room H336, Toronto, ON M4N 3M5, Canada
[3] Womens Coll Hosp, Subst Use Serv, 76 Grenville St,3rd Floor, Toronto, ON M5S 1B2, Canada
[4] St Michaels Hosp, Div Infect Dis, 30 Bond St,4-179 CC North, Toronto, ON M5B 1W8, Canada
关键词
Harm reduction; Retention in care; Injectable opioid agonist; Substance use disorder;
D O I
10.1186/s12954-023-00813-x
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
BackgroundPeople with substance use disorder are at risk of complications of drug use and frequent hospitalization and may continue to use substances during admission to acute care. Acute care harm reduction strategies including oral or injectable prescription opioids may aid in care retention and improve health outcomes in this patient population.Case presentationA 58-year-old woman with refractory opioid use disorder was admitted to hospital for management of dysphagia secondary to esophageal stricture. She received injectable opioid agonist therapy using a continuous ambulatory drug delivery (CADD) pump in order to facilitate completion of her hospital admission.ConclusionsThe patient successfully received acute medical care with the use of a CADD pump for consistent, patient-controlled opioid administration, with the support of an interdisciplinary team and by respecting the patient's own substance use goals.
引用
收藏
页数:5
相关论文
共 8 条
  • [1] A Case report of a continuous ambulatory drug delivery (CADD) pump to deliver opioid agonist treatment in an acute care setting
    Casey Wigg
    Amy Nolen
    Lisa Jauhal
    Malika Sharma
    Harm Reduction Journal, 20
  • [2] Implementation of the continuous ambulatory drug delivery (CADD) pump in the inpatient oncology setting for the safe delivery of high dose opioid infusions in cancer patients
    Moore, Amy
    Espeleta, Jose
    McMenamin, Erin
    ONCOLOGY NURSING FORUM, 2008, 35 (03) : 543 - 544
  • [3] Initiation and Rapid Titration of Methadone in an Acute Care Setting for the Treatment of Opioid Use Disorder: A Case Report
    Hemmons, Patrick
    Bach, Paxton
    Colizza, Kate
    Nolan, Seonaid
    JOURNAL OF ADDICTION MEDICINE, 2019, 13 (05) : 408 - 411
  • [4] Use of a primary care and pharmacy-based model for the delivery of injectable opioid agonist treatment for severe opioid use disorder: a case report
    Wilson, Tyler
    Brar, Rupi
    Sutherland, Christy
    Nolan, Seonaid
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2020, 192 (05) : E115 - E117
  • [5] Use of sustained release dextroamphetamine for the treatment of stimulant use disorder in the setting of injectable opioid agonist treatment in Canada: a case report
    Palis, Heather
    MacDonald, Scott
    Jun, Jennifer
    Oviedo-Joekes, Eugenia
    HARM REDUCTION JOURNAL, 2021, 18 (01)
  • [6] Use of sustained release dextroamphetamine for the treatment of stimulant use disorder in the setting of injectable opioid agonist treatment in Canada: a case report
    Heather Palis
    Scott MacDonald
    Jennifer Jun
    Eugenia Oviedo-Joekes
    Harm Reduction Journal, 18
  • [7] Outpatient parenteral antimicrobial therapy (OPAT) using a continuous ambulatory delivery device (CADD) allowing treatment with multiple daily doses: a brief report of a Norwegian experience
    Skogen, Vegard
    Helleren, Rita
    Jacobsen, Marianne Giske
    Opsal, Anne
    Gallefoss, Frode
    JAC-ANTIMICROBIAL RESISTANCE, 2024, 6 (05):
  • [8] TREATMENT OF ACUTE STENT THROMBOSIS WITH LOCAL UROKINASE THERAPY USING CATHETER-BASED, DRUG-DELIVERY SYSTEMS - A CASE-REPORT
    MITCHEL, JF
    MCKAY, RG
    CATHETERIZATION AND CARDIOVASCULAR DIAGNOSIS, 1995, 34 (02): : 149 - 154